Term ends Sep 6, 2033 · High confidence
20-year base term ends Sep 6, 2033
Sep 6, 2013
Sep 6, 2033
Jun 22, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 6, 2013, when application PCT/US2013/058614, the earliest non-provisional in its chain, was filed (this one was filed Dec 9, 2019) | Sep 6, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,092,569, US 10,456,403, US 10,533,013, US 10,828,307, US 8,940,744, US 9,266,895, US 9,994,576) | resolves to Sep 6, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 6, 2033 | High confidence |
This family
| Application PCT/US2013/058614 | PCT application no patent term | no patent term |
| US 9,266,895 | In force Sep 2033 | Sep 2033 |
| US 8,940,744 | In force Sep 2033 | Sep 2033 |
| US 9,994,576 | In force Sep 2033 | Sep 2033 |
| US 10,533,013 | In force Sep 2033 | Sep 2033 |
| US 11,040,980 | this patent Sep 2033 | Sep 2033 |
| Application 17/324,674 | Abandoned not computed | not computed |
| Application 18/344,167 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 14, 2021 Reel 56241, frame 931 | Owens, Tim; Verner, Erik | Principia Biopharma Inc. | Assignment of Assignor's Interest |
| Sep 16, 2025 Reel 72881, frame 270 | Principia Biopharma Inc. | Principia Biopharma Inc. | Assignee Change of Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,092,569, US 10,456,403, US 10,533,013, US 10,828,307, US 8,940,744, US 9,266,895, US 9,994,576, ends no earlier than this term, so it caps nothing.